Reply: Shouldn't Patients With Paradoxical Emboli and Thrombophilia Be Given Anticoagulant Agents?
- PMID: 33663787
- DOI: 10.1016/j.jcin.2021.01.002
Reply: Shouldn't Patients With Paradoxical Emboli and Thrombophilia Be Given Anticoagulant Agents?
Comment on
-
Patent Foramen Ovale Attributable Cryptogenic Embolism With Thrombophilia Has Higher Risk for Recurrence and Responds to Closure.JACC Cardiovasc Interv. 2020 Dec 14;13(23):2745-2752. doi: 10.1016/j.jcin.2020.09.059. JACC Cardiovasc Interv. 2020. PMID: 33303111 Free PMC article.
-
Shouldn't Patients With Paradoxical Emboli and Thrombophilia Be Given Anticoagulant Agents?JACC Cardiovasc Interv. 2021 Mar 8;14(5):583. doi: 10.1016/j.jcin.2020.12.024. Epub 2021 Mar 1. JACC Cardiovasc Interv. 2021. PMID: 33663788 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources